Catalysts for Rubicon Research Ltd
43 tracked
Mar 5, 2026
approval
IBUPROFEN — FDA approval
Midol
→
Mar 2, 2026
device pma
Alcon Research, Ltd. — AcrySof® IQ ReSTOR Posterior Chamber Intraocular Lenses (PMA supplement)
Rubicon Research Ltd
→
Feb 25, 2026
approval
CETIRIZINE HYDROCHLORIDE — FDA approval
CETIRIZINE HYDROCHLORIDE
→
Jan 2, 2026
approval
BUPRENORPHINE HYDROCHLORIDE — FDA approval
BUPRENORPHINE HYDROCHLORIDE
→
Dec 23, 2025
approval
TRAMADOL HYDROCHLORIDE — FDA approval
tramadol hydrochloride ER
→
Dec 12, 2025
device pma
Alcon Research, Ltd. — AcrySof IQ ReSTOR Posterior Chamber Intraocular Lenses (PMA supplement)
Rubicon Research Ltd
→
Nov 12, 2025
approval
LOPRESSOR (METOPROLOL TARTRATE) — FDA approval
metoprolol tartrate
→
Oct 3, 2025
device pma
Alcon Research, Ltd. — PROVISC Ophthalmic Viscosurgical Device (PMA supplement)
Rubicon Research Ltd
→
Sep 18, 2025
device pma
Alcon Research, Ltd. — AcrySof® IQ ReSTOR® Posterior Chamber Intraocular Lenses (PMA supplement)
Rubicon Research Ltd
→
Sep 3, 2025
approval
TRAMADOL HYDROCHLORIDE — FDA approval
tramadol hydrochloride ER
→
Aug 25, 2025
device pma
Alcon Research, Ltd. — AcrySof® IQ ReSTOR® Posterior Chamber Intraocular Lenses\s (PMA supplement)
Rubicon Research Ltd
→
Jul 25, 2025
device pma
Alcon Research, Ltd. — PROVISC Ophthalmic Viscosurgical Device (PMA supplement)
Rubicon Research Ltd
→
Jul 1, 2025
approval
TRAMADOL HYDROCHLORIDE — FDA approval
tramadol hydrochloride ER
→
Jun 18, 2025
device pma
Alcon Research, Ltd. — AcrySof IQ ReSTOR Posterior Chamber Intraocular Lenses (PMA supplement)
Rubicon Research Ltd
→
Apr 10, 2025
approval
LOPRESSOR (METOPROLOL TARTRATE) — FDA approval
metoprolol tartrate
→
Feb 21, 2025
approval
BUPRENORPHINE HYDROCHLORIDE — FDA approval
BUPRENORPHINE HYDROCHLORIDE
→
Oct 31, 2024
approval
TRAMADOL HYDROCHLORIDE — FDA approval
tramadol hydrochloride ER
→
Apr 4, 2024
approval
TRAMADOL HYDROCHLORIDE — FDA approval
tramadol hydrochloride ER
→
Mar 20, 2024
approval
BUPRENORPHINE HYDROCHLORIDE — FDA approval
BUPRENORPHINE HYDROCHLORIDE
→
Dec 15, 2023
approval
TRAMADOL HYDROCHLORIDE — FDA approval
tramadol hydrochloride ER
→
Dec 15, 2023
approval
BUPRENORPHINE HYDROCHLORIDE — FDA approval
BUPRENORPHINE HYDROCHLORIDE
→
Nov 27, 2023
approval
TRAMADOL HYDROCHLORIDE — FDA approval
tramadol hydrochloride ER
→
Oct 6, 2023
approval
TRAMADOL HYDROCHLORIDE — FDA approval
tramadol hydrochloride ER
→
Oct 6, 2023
approval
TRAMADOL HYDROCHLORIDE — FDA approval
tramadol hydrochloride ER
→
Jun 26, 2023
approval
BUPRENORPHINE HYDROCHLORIDE — FDA approval
BUPRENORPHINE HYDROCHLORIDE
→
Jun 26, 2023
approval
BUPRENORPHINE HYDROCHLORIDE — FDA approval
BUPRENORPHINE HYDROCHLORIDE
→
Dec 16, 2022
approval
BUPRENORPHINE HYDROCHLORIDE — FDA approval
BUPRENORPHINE HYDROCHLORIDE
→
Jun 17, 2022
approval
BUPRENORPHINE HYDROCHLORIDE — FDA approval
BUPRENORPHINE HYDROCHLORIDE
→
Jun 17, 2022
approval
BUPRENORPHINE HYDROCHLORIDE — FDA approval
BUPRENORPHINE HYDROCHLORIDE
→
Jun 13, 2022
approval
BUPRENORPHINE HYDROCHLORIDE — FDA approval
BUPRENORPHINE HYDROCHLORIDE
→